Implantica AG(IMP-A-SDB)

Description: Implantica AG engages in the research and distribution of medical implants in Switzerland. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, the company develops UriControl, a remote controlled artificial urinary sphincter to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and multiple sclerosis patients to urinate on demand using the wireless platform. Further, it provides PotencyFlow for treatment of erectile dysfunction; StomaRestore for eliminating stoma bags; RectalRestore for treatment of fecal incontinence; and AneurysmControl for the treatment of aneurysms. The company was founded in 2015 and is based in Vaduz, Liechtenstein.

---

Keywords: Medical Equipment Obesity Multiple Sclerosis Implant Prosthetics Erectile Dysfunction Urinary Incontinence Spinal Cord Injury Incontinence Treatment Of Erectile Dysfunction Fecal Incontinence Gastroesophageal Reflux Disease Aneurysms

---

Home Page: www.implantica.com

Aeulestrasse 45
Vaduz, 9490
Liechtenstein
Phone: 41 41 539 19 02

---

Officers

Exchange: ST

Country: SE : Sweden

Currency: Swedish krone (kr)